Perspective Therapeutics, Inc. Share Price
Stocks
CATX
US46489V3024
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.980 USD | +1.71% |
|
+1.02% | +8.36% |
| Market Cap | 340M 293M 270M 254M 477M 32.07B 481M 3.19B 1.24B 15.74B 1.28B 1.25B 54.46B | P/E 2026 * |
-2.69x | P/E 2027 * | -2.63x |
|---|---|---|---|---|---|
| Enterprise Value | 153M 132M 121M 114M 214M 14.41B 216M 1.44B 559M 7.07B 573M 561M 24.47B | EV / Sales 2026 * |
366x | EV / Sales 2027 * | 56.5x |
| Free-Float |
89.19% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Perspective Therapeutics, Inc.
| 1 day | +1.71% | ||
| 1 week | +1.02% | ||
| Current month | -24.37% | ||
| 1 month | -22.60% | ||
| 3 months | -39.80% | ||
| 6 months | +15.06% | ||
| Current year | +8.36% |
| 1 week | 2.86 |  | 3.12 |
| 1 month | 2.85 | | 4.34 |
| Current year | 2.25 | | 6.16 |
| 1 year | 1.96 | | 6.16 |
| 3 years | 1.6 | | 19.05 |
| 5 years | 1.6 | | 19.05 |
| 10 years | 1.6 | | 28.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Johan Spoor
CEO | Chief Executive Officer | 54 | 04/02/2023 |
Joel D. Sendek
DFI | Director of Finance/CFO | 59 | 03/09/2025 |
David Hauser
CTO | Chief Tech/Sci/R&D Officer | - | 31/03/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Johan Spoor
BRD | Director/Board Member | 54 | 04/02/2023 |
Lori Woods
CHM | Chairman | 63 | 02/02/2023 |
| Director/Board Member | 60 | 04/02/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03-01 | Free | Chief Technology Officer | 150,000 | 0.1317% | ||
| 03-01 | Free | Director | 50,000 | 0.0439% | ||
| 03-01 | Free | Director | 50,000 | 0.0439% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.71% | +1.02% | -15.58% | -57.93% | 340M | |
| -0.22% | -1.14% | -11.88% | -13.09% | 43.44B | |
| +0.76% | +9.42% | +303.09% | +540.82% | 33.54B | |
| -4.74% | -6.31% | +10.75% | -20.99% | 28.48B | |
| -0.47% | -0.35% | +3.38% | +31.20% | 29.2B | |
| +0.06% | +4.36% | +13.31% | +21.11% | 25.34B | |
| -0.02% | +10.18% | - | - | 14.36B | |
| -0.98% | -1.86% | +53.43% | +106.06% | 13.05B | |
| -0.29% | -4.40% | +3.13% | +1.69% | 12.67B | |
| +1.67% | +1.35% | +105.56% | +81.16% | 12.28B | |
| Average | -0.25% | +1.30% | +51.69% | +76.67% | 21.27B | |
| Weighted average by Cap. | -0.60% | +1.35% | +62.62% | +104.88% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 418K 360K 331K 312K 586K 39.42M 591K 3.93M 1.53M 19.35M 1.57M 1.53M 66.93M | 488K 421K 387K 364K 684K 46.01M 690K 4.58M 1.78M 22.58M 1.83M 1.79M 78.12M |
| Net income | -121M -104M -95.95M -90.31M -170M -11.42B -171M -1.14B -443M -5.6B -454M -444M -19.38B | -138M -119M -110M -103M -194M -13.04B -195M -1.3B -506M -6.4B -518M -507M -22.14B |
| Net Debt | -187M -161M -148M -140M -262M -17.66B -265M -1.76B -685M -8.67B -702M -687M -29.98B | -312M -269M -248M -233M -438M -29.47B -442M -2.94B -1.14B -14.47B -1.17B -1.15B -50.04B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/06/26 | 2.980 $ | +1.71% | 2,046,670 |
| 16/06/26 | 2.930 $ | -0.34% | 765,604 |
| 15/06/26 | 2.940 $ | -0.34% | 1,758,437 |
| 12/06/26 | 2.950 $ | -0.67% | 1,027,229 |
| 11/06/26 | 2.970 $ | +0.68% | 1,052,849 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CATX Stock
Select your edition
All financial news and data tailored to specific country editions
